Intra-Cellular Therapies (ITCI) stock rose more than 35% premarket after Johnson & Johnson (JNJ) agreed to buy the biopharmaceutical company for $132 a share. Read more: ...

Americans will have more opportunities to eat ShackBurgers in coming years, as fast-casual chain Shake Shack plans to more ...

Macy’s warned of weaker revenue in the crucial year-end period, saying net sales will likely come in at the low end or slightly below its previously guided range of $7.8 billion to $8 billion.

Global oil prices are on track to settle at their highest level since August, boosted by the prospect of new sanctions ...

Johnson & Johnson agreed to acquire Intra-Cellular Therapies for $132 a share in cash for a total equity value of about $14.6 billion.

Live updates on stocks and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Predicted losses from the Los Angeles wildfires are increasing, as the blazes destroy more properties. The disaster is set to be the most expensive fire in modern global history, according to ...

The Bills’ Josh Allen and the Ravens’ Lamar Jackson, the two MVP favorites, will meet in the next round of the postseason ...

Some senators are advising the Pentagon nominee to tone down his combative style to avoid a clash that could cost him key ...

BMW group sales fell 4% in 2024 as the German automaker was hit by technical issues and subdued demand in China.

Containment of the blazes, which have killed 24 people, improved over the weekend but resurgent winds could thwart progress.